Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

778 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
Trotta AM, Santagata S, Zanotta S, D'Alterio C, Napolitano M, Rea G, Camerlingo R, Esposito F, Lamantia E, Anniciello A, Botti G, Longo N, Botti G, Pignata S, Perdonà S, Scala S. Trotta AM, et al. Among authors: botti g. J Exp Clin Cancer Res. 2018 Dec 4;37(1):297. doi: 10.1186/s13046-018-0952-7. J Exp Clin Cancer Res. 2018. PMID: 30514329 Free PMC article.
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.
D'Alterio C, Buoncervello M, Ieranò C, Napolitano M, Portella L, Rea G, Barbieri A, Luciano A, Scognamiglio G, Tatangelo F, Anniciello AM, Monaco M, Cavalcanti E, Maiolino P, Romagnoli G, Arra C, Botti G, Gabriele L, Scala S. D'Alterio C, et al. Among authors: botti g. J Exp Clin Cancer Res. 2019 Oct 28;38(1):432. doi: 10.1186/s13046-019-1420-8. J Exp Clin Cancer Res. 2019. PMID: 31661001 Free PMC article.
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.
Franco R, Zappavigna S, Gigantino V, Luce A, Cantile M, Cerrone M, Facchini G, Perdonà S, Pignata S, Di Lorenzo G, Chieffi S, Vitale G, De Sio M, Sgambato A, Botti G, Yousif AM, Novellino E, Grieco P, Caraglia M. Franco R, et al. Among authors: botti g. J Exp Clin Cancer Res. 2014 Jun 3;33(1):48. doi: 10.1186/1756-9966-33-48. J Exp Clin Cancer Res. 2014. PMID: 24893613 Free PMC article.
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells.
Ottaiano A, di Palma A, Napolitano M, Pisano C, Pignata S, Tatangelo F, Botti G, Acquaviva AM, Castello G, Ascierto PA, Iaffaioli RV, Scala S. Ottaiano A, et al. Among authors: botti g. Cancer Immunol Immunother. 2005 Aug;54(8):781-91. doi: 10.1007/s00262-004-0636-3. Epub 2004 Dec 11. Cancer Immunol Immunother. 2005. PMID: 15592929 Free PMC article.
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells.
Ieranò C, D'Alterio C, Giarra S, Napolitano M, Rea G, Portella L, Santagata A, Trotta AM, Barbieri A, Campani V, Luciano A, Arra C, Anniciello AM, Botti G, Mayol L, De Rosa G, Pacelli R, Scala S. Ieranò C, et al. Among authors: botti g. Cell Death Dis. 2019 Jul 22;10(8):562. doi: 10.1038/s41419-019-1796-6. Cell Death Dis. 2019. PMID: 31332163 Free PMC article.
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
Ottaiano A, Scala S, Normanno N, Napolitano M, Capozzi M, Rachiglio AM, Roma C, Trotta AM, D'Alterio C, Portella L, Romano C, Cassata A, Casaretti R, Silvestro L, Nappi A, Tafuto S, Avallone A, De Stefano A, Tamburini M, Picone C, Petrillo A, Izzo F, Palaia R, Albino V, Amore A, Belli A, Pace U, Di Marzo M, Chiodini P, Botti G, De Feo G, Delrio P, Nasti G. Ottaiano A, et al. Among authors: botti g. BMC Cancer. 2019 Sep 9;19(1):899. doi: 10.1186/s12885-019-6109-z. BMC Cancer. 2019. PMID: 31500586 Free PMC article.
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer.
Ottaiano A, Circelli L, Lombardi A, Scala S, Martucci N, Galon J, Buonanno M, Scognamiglio G, Botti G, Hermitte F, Savarese G, D'Amore L, Tatangelo F, Di Mauro A, Liguori G, Trotta AM, Napolitano M, Capozzi M, Tafuto S, Perri F, La Rocca A, Caraglia M, Nasti G. Ottaiano A, et al. Among authors: botti g. Cell Death Dis. 2020 Apr 24;11(4):275. doi: 10.1038/s41419-020-2480-6. Cell Death Dis. 2020. PMID: 32332709 Free PMC article.
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer.
D'Alterio C, Zannetti A, Trotta AM, Ieranò C, Napolitano M, Rea G, Greco A, Maiolino P, Albanese S, Scognamiglio G, Tatangelo F, Tafuto S, Portella L, Santagata S, Nasti G, Ottaiano A, Pacelli R, Delrio P, Botti G, Scala S. D'Alterio C, et al. Among authors: botti g. Cancers (Basel). 2020 Jul 18;12(7):1952. doi: 10.3390/cancers12071952. Cancers (Basel). 2020. PMID: 32708431 Free PMC article.
778 results